103 related articles for article (PubMed ID: 10878938)
21. Lymphopenic effect of carbamazepine in a patient with chronic lymphocytic leukemia.
Silverman DA; Chapron DJ
Ann Pharmacother; 1995 Sep; 29(9):865-7. PubMed ID: 8547733
[TBL] [Abstract][Full Text] [Related]
22. [Clinical analysis of 10 patients with chronic lymphoid leukemia].
Fukuda T; Makino S; Tamura K; Suzumiya J; Kimura N; Ohshima K; Kikuchi M; Sagawa K
Rinsho Ketsueki; 1992 Aug; 33(8):1017-24. PubMed ID: 1404856
[TBL] [Abstract][Full Text] [Related]
23. Histopathology of B-cell chronic lymphocytic leukemia.
Pileri SA; Sabattini E; Agostinelli C; Bodega L; Rossi M; Zinzani PL; Marafioti T
Hematol Oncol Clin North Am; 2004 Aug; 18(4):807-26, viii. PubMed ID: 15325700
[TBL] [Abstract][Full Text] [Related]
24. Blood microvesicles during chronic lymphoproliferative diseases.
Domnikova NP; Dolgikh TY; Sholenberg EV; Vorontsova EV; Goreva OB; Mel'nikova EV; Gorbachenko EA; Grishanova AY
Bull Exp Biol Med; 2013 Nov; 156(1):94-7. PubMed ID: 24319739
[TBL] [Abstract][Full Text] [Related]
25. Retinal complications associated with hyperviscosity in chronic lymphocytic leukaemia.
Davies CE; Whitelocke RA; Agrawal S
Intern Med J; 2008 Feb; 38(2):140. PubMed ID: 18290831
[No Abstract] [Full Text] [Related]
26. Evaluation of morpho/immunological telehaematology file exchanges for the inclusion of patients with chronic lymphocytic leukaemia in a therapeutic trial.
Lesesve J; Palmiéri A; Brion A; Feugier P; Mahé B; Garand R;
Int J Lab Hematol; 2008 Jun; 30(3):256-8. PubMed ID: 18479305
[No Abstract] [Full Text] [Related]
27. Hyperthermic effects on peripheral lymphocytes isolated from a chronic lymphocytic lymphoma/leukemia patient in vitro.
Nakayama J; Yasumoto S; Kabemura M; Imayama S; Asahi M; Urabe H
J Dermatol; 1987 Jun; 14(3):187-94. PubMed ID: 3312334
[No Abstract] [Full Text] [Related]
28. No effect of lysis solutions on absolute CD19+ lymphocytes count and CD45 index in chronic lymphocytic leukemia.
Mekouar H; Mullier F; Dinon Q; Bailly N; Cornet Y; Chatelain B
Cytometry B Clin Cytom; 2011 Nov; 80(6):369-72. PubMed ID: 21638772
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapy.
Rai KR
Exp Hematol; 2007 Apr; 35(4 Suppl 1):134-6. PubMed ID: 17379098
[No Abstract] [Full Text] [Related]
30. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.
Perry C; Herishanu Y; Hazan-Halevy I; Kay S; Bdolach N; Naparstek E; Polliack A; Grisaru D
Leuk Lymphoma; 2012 Sep; 53(9):1807-10. PubMed ID: 22242820
[No Abstract] [Full Text] [Related]
32. [Biochemical studies of the supernatant of leukemia cell cultures].
Kiersnowska-Rogowska B
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():21-52. PubMed ID: 6101032
[No Abstract] [Full Text] [Related]
33. [The lymphocytes of chronic lymphoid leukemia. Diagnostic, physiologic and prognostic significance].
Binet JL
Bull Acad Natl Med; 1989 Jan; 173(1):73-6; discussion 77. PubMed ID: 2788480
[TBL] [Abstract][Full Text] [Related]
34. Increased percentage of activated T lymphocytes in B cell lymphocytic leukaemia (B-CLL) patients.
Garcia-Suarez J; Prieto A; Reyes E; Merino JL; Alvarez-Mon M
Br J Haematol; 1991 Dec; 79(4):657-8. PubMed ID: 1772793
[No Abstract] [Full Text] [Related]
35. Chronic lymphocytic leukaemia--a personal story.
Politzer WM
S Afr Med J; 1999 Jan; 89(1):45-6. PubMed ID: 10070411
[No Abstract] [Full Text] [Related]
36. Chronic lymphocytic leukaemia with binucleated lymphocytes.
Amouroux I; Mossafa H; Gentilhomme O; Girot R; Flandrin G; Troussard X
Leuk Lymphoma; 1997 Nov; 27(5-6):533-7. PubMed ID: 9477136
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous presentation of chronic lymphocytic leukemia as unique extramedullar involvement in a patient with normal peripheral blood lymphocyte count (monoclonal B-cell lymphocytosis).
Tapia G; Mate JL; Fuente MJ; Navarro JT; Fernández-Figueras MT; Juncà J; Ferrándiz C; Ariza A
J Cutan Pathol; 2013 Aug; 40(8):740-4. PubMed ID: 23639136
[TBL] [Abstract][Full Text] [Related]
38. Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemia.
Shvidel L; Bairey O; Tadmor T; Braester A; Ruchlemer R; Fineman R; Joffe E; Berrebi A; Polliack A;
Anticancer Res; 2015 May; 35(5):2861-6. PubMed ID: 25964568
[TBL] [Abstract][Full Text] [Related]
39. A population-based assessment of the prognostic value of the CD19 positive lymphocyte count in B-cell chronic lymphocytic leukemia using Cox and Markov models.
Cailliod R; Quantin C; Carli PM; Jooste V; Le Teuff G; Binquet C; Maynadie M
Eur J Epidemiol; 2005; 20(12):993-1001. PubMed ID: 16331430
[TBL] [Abstract][Full Text] [Related]
40. [Possibilities of estimating the density of lymphocytic surface receptors from the mean fluorescence strength by flow cytofluorometry. Standardization of analytical conditions].
Naumova EV; Pochtar' ME; Luzin MN
Klin Lab Diagn; 2008 Oct; (10):43-8. PubMed ID: 19069446
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
